Skip to Main Content

Paper Details

Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study.
J Clin Rheumatol
2
2022
Author NameAffiliation
John D ReveilleUniversity of Texas McGovern Medical School
  • 1 - 1

Datasets

Release 1.2